Abstract
We sought to evaluate the delays, between-centre variations in practice, and opportunity costs attributable to delays in research governance approval of clinical trials in the United Kingdom.
Original language | English |
---|---|
Pages (from-to) | 101-4 |
Number of pages | 4 |
Journal | Journal of the Royal Society of Medicine |
Volume | 100 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2007 |
Keywords / Materials (for Non-textual outputs)
- Biomedical Research
- Costs and Cost Analysis
- Humans
- Multicenter Studies as Topic
- Organizational Policy
- Randomized Controlled Trials as Topic
- Retrospective Studies